PSYCHOGENICS, INC.

Basic Information

765 OLD SAW MILL RIVER RD
TARRYTOWN, NY, 10591-6702

Company Profile

n/a

Additional Details

Field Value
DUNS: 4812744
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Predictive Smoking Cessation Preclinical Battery

    Amount: $1,607,051.00

    DESCRIPTION (provided by applicant): Despite great advances in both the understanding of the neurobiology of addiction and the development and approval of smoking cessation therapies, a significant ne ...

    SBIR Phase II 2014 Department of Health and Human Services
  2. Predictive Smoking Cessation Preclinical Battery

    Amount: $829,176.00

    DESCRIPTION (provided by applicant): Despite great advances in both the understanding of the neurobiology of addiction and the development and approval of smoking cessation therapies, a significant ne ...

    SBIR Phase I 2012 Department of Health and Human Services
  3. Eltoprazine for the Treatment of Cognitive Dysfunction Assoc. With Schizophrenia

    Amount: $700,000.00

    DESCRIPTION (provided by applicant): Schizophrenia is a common and highly disabling psychiatric disorder with a population prevalence around 1%. The manifestations of schizophrenia fall into three maj ...

    SBIR Phase I 2011 Department of Health and Human Services
  4. Prodrugs of NAAG Peptidase Inhibitors for the Treatment of Schizophrenia

    Amount: $620,426.00

    DESCRIPTION (provided by applicant): Schizophrenia is a chronic, severe, and disabling brain disease. Nearly 1 percent of the population develops schizophrenia during their lifetime - more than 2 mill ...

    SBIR Phase I 2008 Department of Health and Human Services
  5. HDAC6-Selective Inhibitors for Pancreatic Cancer Treatment

    Amount: $366,682.00

    DESCRIPTION (provided by applicant): Pancreatic cancer is the fifth leading cause of cancer death in the US. Despite tremendous efforts aimed at understanding its molecular biology, conventional treat ...

    SBIR Phase I 2008 Department of Health and Human Services
  6. NAAG Peptidase Inhibitors for the Treatment of Traumatic Brain Injury

    Amount: $760,811.00

    DESCRIPTION (provided by applicant): Traumatic brain injury (TBI) is a serious public health concern. It is estimated that severe TBI will become the third most common cause of death and disability gl ...

    SBIR Phase I 2008 Department of Health and Human Services
  7. High Throughput in Vivo Drug Discovery- Phase II

    Amount: $1,350,000.00

    DESCRIPTION (provided by applicant): This Phase II application is being submitted in response to a continuing NIMH program announcement for Pharmacological Agents and Drugs for Mental Disorders. The g ...

    SBIR Phase II 2008 Department of Health and Human Services
  8. Nicotinic Ligands as Smoking Cessation Agents

    Amount: $577,800.00

    DESCRIPTION (provided by applicant): Tobacco use and nicotine addiction are an immense burden on the public health. There are an estimated 44.5 million (21%) adult smokers and an estimated 3.75 millio ...

    STTR Phase I 2007 Department of Health and Human Services
  9. Development of GSK-3 Beta Inhibitors for the Treatment of Parkinson's Disease

    Amount: $564,868.00

    DESCRIPTION (provided by applicant): Parkinson's disease (PD), a chronic and progressive neurological condition and one of aging and age- related diseases, affects approximately 1.5 million people in ...

    SBIR Phase I 2007 Department of Health and Human Services
  10. High Throughput Behavioral Testing For Novel Antidepressants

    Amount: $500,000.00

    DESCRIPTION (provided by applicant): CONFIDENTIAL Project Summary/Abstract This application is being submitted in response to an NIMH program announcement for Pharmacological Agents and Drugs for Ment ...

    SBIR Phase I 2007 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government